PINOVA Capital takes a participation in Hemoteq AG

As part of the transaction, CFO Thomas Löwen also acquires a stake in the company.

Hemoteq is a specialist in the market for biocompatible and drug eluting surfaces.

The company develops ultra-thin functional coatings and surface modification solutions for medical devices, supports its customers in obtaining regulatory approval and provides clean room capacities for volume production.

Its products focus on applications in cardiology, ophthalmology, orthopedics and dentistry.

Hemoteq's customer base includes European, North American and Asian medical device manufacturers. The company was founded in 1999.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• DACH
• Healthcare
• Expansion
• Germany